CircRNA-UCK2 increased TET1 inhibits proliferation and invasion of prostate cancer cells via sponge miRNA-767-5p

A majority of the patients with advanced prostate cancer initially respond to androgen deprivation therapy and enzalutamide therapy, but eventually enter the castration-resistant prostate cancer (CRPC) phase. Some studies have shown that the activation of other signalling pathways in CRPC cells repl...

Full description

Bibliographic Details
Main Authors: Xiang Zhendong, Xu Chengdang, Wu Gang, Liu Bo, Wu Denglong
Format: Article
Language:English
Published: De Gruyter 2019-11-01
Series:Open Medicine
Subjects:
Online Access:http://www.degruyter.com/view/j/med.2019.14.issue-1/med-2019-0097/med-2019-0097.xml?format=INT